ASCIA Action, First Aid, Management, Travel and Treatment Plans and Guides


ASCIA Action Plans for Anaphylaxis (RED)

The following 2020 ASCIA Action Plans are the latest versions. However, the 2018 and 2017 versions of ASCIA Action Plans are still valid for use throughout 2020 and 2021, or until the due date for review stated on the plan. 

For information about recent changes to ASCIA Action Plans go to www.allergy.org.au/hp/anaphylaxis/action-plans-for-allergic-reactions-faq 

ASCIA Action Plan for Anaphylaxis (RED) 2020 EpiPen®

This plan is provided to people with allergies who have been prescribed EpiPen® adrenaline autoinjectors.

pdfASCIA Action Plan Anaphylaxis EpiPen Red 2020

ASCIA Action Plan for Anaphylaxis (RED) 2020 Generic

This plan is provided to people with allergies who have been prescribed any brand of adrenaline autoinjectors. 

pdfASCIA Action Plan Anaphylaxis Generic Red 2020

ASCIA Action Plan for Allergic Reactions (GREEN) 2020

This plan is provided to people with allergies who have not been prescribed adrenaline autoinjector/s. 

pdfASCIA Action Plan Allergic Reactions Green 2020

An ASCIA Action Plan for Anaphylaxis for use with adrenaline autoinjectors on airlines is available upon request. This plan is should be stored with adrenaline autoinjectors in emergency medical kits on airlines. 

ASCIA First Aid Plans for Anaphylaxis (ORANGE)

Note: These have replaced the general versions of ASCIA Action Plans for Anaphylaxis (ORANGE)

ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2020 EpiPen®

This plan can be used as a poster or stored with general use EpiPen® adrenaline autoinjectors.

pdfASCIA First Aid Anaphylaxis EpiPen Orange 2020

ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2020 Generic

This plan can be used as a poster or stored with general use adrenaline autoinjectors. 

pdfASCIA First Aid Anaphylaxis Generic Orange 2020

For translated versions of ASCIA First Aid for Anaphylaxis go to www.allergy.org.au/hp/anaphylaxis#ta5

For further information about ASCIA Action Plans and other anaphylaxis resources go to www.allergy.org.au/anaphylaxis   

Important information:

1. ASCIA Action Plans should be reviewed and reissued when patients are reassessed by their doctor or nurse practitioner, and each time they obtain a new adrenaline autoinjector prescription, which is approximately every 12 to 18 months. If there are no changes in diagnosis or management the medical information on the ASCIA Action Plan may not need to be updated. However, if the patient is a child, the photo should be updated each time, so they can be easily identified.

2. ASCIA Action Plans for Anaphylaxis can be used for people with food, insect, tick and drug allergies, or any other allergy that can result in a severe allergic reaction (anaphylaxis).  

3. Adrenaline autoinjectors contain a single, fixed dose of adrenaline and are designed to be used by anyone (medical training is not required), including friends, teacher, childcare worker, parents or patients (if they are not too unwell or too young).

4. It is generally recommended that people who have an adrenaline autoinjector should also wear a medical identification/emergency response emblem  or other medical identification.

5. ASCIA Action Plans should be used as part of a comprehensive anaphylaxis management plan that includes:

  • Age appropriate education of people with allergies and their peers or colleagues. 
  • Training in the recognition and management of allergic reactions.
  • Development of strategies to reduce the risk of accidental exposure.
  • An ASCIA Action Plan to be used as an emergency response plan for when exposure to allergens occurs. 

ASCIA Travel Plan and Checklist

ASCIA Travel Plan for people at risk of anaphylaxis

pdfASCIA Travel Plan Anaphylaxis 2020
 

ASCIA Travelling with allergy, asthma and anaphylaxis checklist

pdfASCIA Checklist: Travelling with allergy, asthma or anaphylaxis 2020

ASCIA Action Plan for Eczema and Guide to Eczema Management

ASCIA Action Plan
for Eczema 

pdfASCIA Action Plan for Eczema  

ASCIA Guide to Eczema
Management

pdfASCIA Guide Eczema Management 2018

ASCIA Action Plan for FPIES (food protein-induced enterocolitis syndrome) 

ASCIA Action Plan for FPIES (food protein-induced enterocolitis syndrome) 

pdfASCIA Action Plan FPIES 2020 

ASCIA Immunodeficency Plans 

ASCIA SCIg (subcutaneous immunoglobulin) Treatment Plan

pdfASCIA SCIg Treatment Plan 

ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy) 

pdfASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy) 

ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy

pdfASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy

ASCIA Management Plan for Hereditary Angioedema (HAE)

 ASCIA Treatment Plan for Allergic Rhinitis

 ASCIA Treatment Plan for Subcutaneous Immunotherapy (SCIT)

Content updated August 2020

Mod ASCIA Member
Donate to AIFA
go to NAS website
Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.